Dr. Pfeffer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis Street
Brigham & Women's Hosp
Boston, MA 02115Phone+1 617-732-5681
Education & Training
- Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1979 - 1980
- Brigham and Women's HospitalResidency, Internal Medicine, 1976 - 1979
- University of Oklahoma College of MedicineClass of 1976
Certifications & Licensure
- MA State Medical License 1980 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- Boston Magazine Castle Connolly, 2008-2013
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- ARISE - Aggressive Reduction of Inflammation Stops Events Start of enrollment: 2003 Jun 01
Publications & Presentations
PubMed
- 1 citationsDuration of Heart Failure With Preserved Ejection Fraction and Outcomes With Sacubitril/Valsartan: Insights From the PARAGON-HF Trial.John W Ostrominski, Brian L Claggett, Milton Packer, Marc A Pfeffer, Carolyn S P Lam
Journal of Cardiac Failure. 2023-11-01 - 1391 citationsRenin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.Muthiah Vaduganathan, Orly Vardeny, Thomas Michel, John J.V. McMurray, Marc A. Pfeffer
The New England Journal of Medicine. 2020-03-30 - 22 citationsPredictors of sudden cardiac death in high-risk patients following a myocardial infarctionKieran F. Docherty, João Pedro Ferreira, Abhinav Sharma, Nicolas Girerd, John Gregson
European Journal of Heart Failure. 2020-01-16
Journal Articles
- Atrial Fibrillation in Heart Failure with Preserved Ejection FractionAmil M Shah, Nancy K Sweitzer, Akshay S Desai, James C Fang, Sanjeev Saksena, Bertram Pitt, Sanjiv J Shah, Marc A Pfeffer, Scott D Solomon, ScienceDirect
Lectures
- Progression from Hypertension to Heart Failure: Mechanisms, Epidemiology, and Prevention55th Annual Scientific Session & Expo, Atlanta, Georgia, USA
- Progression from Hypertension to Heart Failure: Mechanisms, Epidemiology, and PreventionAmerican College of Cardiology, 55th Annual Scientific Session & Expo, Atlanta, Georgia, USA
- TOPCAT: Effects of Spironolactone on CV Outcomes in Patients With Heart Failure With Preserved Ejection FractionAmerican Heart Association, Scientific Sessions 2013, Dallas, Texas, USA
- Join now to see all
Other
- Angiotensin II receptor blockers in heart failure due to systolic dysfunction: Therapeutic usePfeffer MA, Colucci WS
http://www.uptodate.com/contents/angiotensin-ii-receptor-blockers-in-heart-failure-due-to-systolic-d
UpToDate, Wolters Kluwer Health - 2012-06-29
Authored Content
- Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial CohortJune 2017
- Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial CohortJune 2017
- Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial CohortJune 2017
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsMarch 2017
- Join now to see all
Press Mentions
- PARADISE-MI: Sacubitril-Valsartan Fails to Outperform ACE Inhibitor After MINovember 11th, 2021
- ACC.21: Late-Breaking Science Brings Practice-Changing InsightsJune 17th, 2021
- Cover Story | ACC.21: Reuniting the Cardiovascular Community; Reimagining Global Heart HealthJune 17th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: